Gaudium IVF & Women Health Share Price Today | Stock Price & Gaudium IVF & Women Health Share Screener
As of November 18, 2026, the live Gaudium IVF & Women Health share price (NSE: GAUDIUMIVF) is ₹97.40 on NSE and ₹97.55 on BSE, down 4.61% from the previous close, with shares trading between ₹96.67 and ₹104.00 in today's trading session, and a 52-week range of ₹70.67–₹125.47. Track Gaudium IVF & Women Health market worth to gauge the company's total market size. Use the Gaudium IVF & Women Health stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Gaudium IVF & Women Health opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹31 and net income of ₹8, with EBITDA of ₹12, an operating margin of 40.0% and a profit margin of 25.8%.
Gaudium IVF & Women Health Share Price Chart
Track the current stock price of Gaudium IVF & Women Health with an interactive chart. Analyse GAUDIUMIVF share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Gaudium IVF & Women Health stock quote in one place.
The quote of ₹97.40 sits between the 52-week low of ₹70.67 and the 52-week high of ₹125.47, and the latest session moved -4.61% from the previous close.
Gaudium IVF & Women Health Company Profile - Fundamental Screener
Screen Gaudium IVF & Women Health company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GAUDIUMIVF shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Healthcare Services industry, and it trades under ISIN INE0P8B01020.
Company Details
Classification
Identifiers and Leadership
Gaudium IVF & Women Health Balance Sheet Screener
Screen GAUDIUMIVF balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹193, up from ₹89 in 2025.
Latest statistics put total assets at ₹193 and shareholder funds at ₹152, with a leverage ratio of 0.23.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
Assets |
|||||
| Total Assets | 193 | 89 | 57 | 37 | 18 |
| Current Assets | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 18 | 18 | 19 | 18 | 4 |
Liabilities |
|||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 4 | 4 | 4 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||
| Total Equity | 152 | 46 | 33 | 23 | 9 |
| Share Capital | 36 | 31 | 1 | 1 | 1 |
| Reserves & Surplus | 116 | 16 | 32 | 22 | 8 |
Gaudium IVF & Women Health Income Statement Screener - Profit & Revenue Analysis
Screen Gaudium IVF & Women Health income statement and profit fundamentals. Analyze GAUDIUMIVF quarterly results. Gaudium IVF & Women Health reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹31 and net profit was ₹8, equal to earnings per unit of ₹1.34, at an operating margin of 40%.
In that period expenses were ₹18, interest cost ₹1 and tax ₹2. The next period listed, 2026-Jun, shows revenue of ₹21 and net profit of ₹2.
| Item | 2026-Mar | 2026-Jun | 2026-Sept | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||||
| Revenue | 31 | 21 | 39 | 27 | 18 | 32 | 25 | 14 |
| Expenses | 18 | 17 | 24 | 18 | 13 | 18 | 18 | 9 |
Operating Costs and Margins | ||||||||
| EBITDA | 12 | 4 | 15 | 9 | 5 | 14 | 7 | 6 |
| Operating Profit % | 40.00% | 13.00% | 36.00% | 32.00% | 29.00% | 43.00% | 27.00% | 39.00% |
| Depreciation | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 |
| Interest | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 |
Profit and Earnings | ||||||||
| Profit Before Tax | 10 | 3 | 13 | 8 | 4 | 13 | 5 | 5 |
| Tax | 2 | 1 | 3 | 2 | 1 | 3 | 1 | 1 |
| Net Profit | 8 | 2 | 9 | 7 | 3 | 9 | 4 | 3 |
| EPS | 1.34 | 0.25 | 1.29 | 1.05 | 0.50 | 1.53 | 0.59 | 0.55 |
Gaudium IVF & Women Health Cash Flow Screener - Liquidity Fundamentals
Screen GAUDIUMIVF cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹7, and net cash flow was an inflow of ₹2.
Over the same period, investing activities used ₹88 and financing activities provided ₹82.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|
Cash from Operations and Investing | |||||
| Operating Activities | 7 | 9 | 3 | 24 | -1 |
| Investing Activities | -88 | -15 | -5 | -16 | -1 |
Financing and Net Cash | |||||
| Financing Activities | 82 | 2 | -1 | 5 | 3 |
| Net Cash Flow | 2 | -5 | -3 | 14 | 0 |
Gaudium IVF & Women Health Shareholding Pattern Screener
See Gaudium IVF & Women Health shareholding pattern with promoter, FII, and DII holdings. Check Gaudium IVF & Women Health promoter holding and ownership changes for GAUDIUMIVF on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Feb, promoters held 71.29%, foreign institutions 9.24%, domestic institutions 5.11% and the public 13.52%, spread across 7 shareholders.
The shareholder count was 7 in 2026-Feb, compared with 19,854 in 2026-Mar.
| Item | 2026-Feb | 2026-Mar | 2026-Jun | 2026-Sept | 2025-Jan | 2025-Sept |
|---|---|---|---|---|---|---|
Promoter Holding | ||||||
| Promoter Holding | 71.29% | 71.29% | 71.29% | 71.29% | 99.98% | 99.98% |
Institutional Investors | ||||||
| FII Holding | 9.24% | 6.70% | 3.02% | 1.19% | 0.00% | 0.00% |
| DII Holding | 5.11% | 2.62% | 2.22% | 2.22% | 0.00% | 0.00% |
Government, Public and Others | ||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 13.52% | 14.67% | 16.78% | 18.19% | 0.00% | 0.00% |
| Other Holding | 0.84% | 4.73% | 6.69% | 7.10% | 0.02% | 0.02% |
| Shareholder Count | 7 | 19,854 | 21,910 | 24,051 | 7 | 7 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Gaudium IVF & Women Health. Gaudium IVF & Women Health dividend yield can be compared with peers and other stocks in the market.
Gaudium IVF & Women Health Stock Index Membership - Nifty & Sensex
See which indices include Gaudium IVF & Women Health stock. Check GAUDIUMIVF index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Gaudium IVF & Women Health Market Events Screener - Corporate Actions
Get Gaudium IVF & Women Health corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Gaudium IVF & Women Health stock events that may affect GAUDIUMIVF share price, along with derivatives, futures and options activity and sector gainers.
5 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 12, 2026, with a record date of November 12, 2026.
It is followed by Annual General Meeting dated September 28, 2026 and Quarterly Result Announcement dated August 13, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-11-12 | 2026-11-12 | Quarterly Result Announcement | NA | 4.50% |
| 2026-09-28 | 2026-09-28 | Annual General Meeting | NA | -6.40% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | -6.91% |
| 2026-05-28 | 2026-05-28 | Quarterly Result Announcement | NA | 0.04% |
| 2026-03-18 | 2026-03-18 | Quarterly Result Announcement | NA | 5.06% |
Gaudium IVF & Women Health Competitors Screener - Peer Stocks Comparison
Screen GAUDIUMIVF competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 127,213 | 53.50 | 25,420 | 15.58% | 2,003 | 61.89 |
| Max Healthcare Institute | 100,981 | 72.60 | 8,536 | 18.82% | 1,442 | 76.17 |
| Manipal Health Enterprises | 91,984 | 105.70 | 10,521 | 25.80% | 917 | 60.80 |
| Aster DM Quality Care | 65,009 | 114.20 | 4,769 | 11.25% | 427 | 57.55 |
| Fortis Healthcare | 60,936 | 57.30 | 9,179 | 16.93% | 1,064 | 57.30 |
| Global Health | 39,228 | 63.30 | 4,509 | 19.56% | 554 | 64.64 |
| Narayana Hrudayalaya | 39,012 | 45.30 | 7,996 | 43.43% | 811 | 61.49 |
| Dr. Lal Path Labs | 33,266 | 56.50 | 2,864 | 12.11% | 510 | 54.28 |
| Krishna Institute of Medical Sciences | 32,191 | 163.70 | 3,931 | 28.16% | 242 | 66.73 |
| Syngene International | 17,584 | 94.20 | 3,809 | 2.56% | 317 | 61.78 |
Gaudium IVF & Women Health Company Announcements - News & Reports Screener
Screen GAUDIUMIVF latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated November 18, 2026 and November 18, 2026.
| Date | Update | Actions |
|---|---|---|
| Announcement under Regulation 30 (LODR)-Newspaper Publication | - | |
| 2026-11-18 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-11-18 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-11-17 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-11-14 | Rectification Of Inadvertent Typographical Error In The Unaudited Consolidated Financial Results Submitted As Part Of The Outcome Of The Board Meeting Held On November 12 2026 | - |
| 2026-11-14 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-11-14 | Revised Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information Pursuant To Regulation 8(2) Of SEBI (PIT) Regulations 2015. | - |
| 2026-11-14 | Statement Of Deviation(S) Or Variation(S) Under Regulation 32 | - |
| 2026-11-14 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-11-14 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-11-14 | Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2026 | - |
| 2026-11-14 | Board Meeting Outcome for For Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2026 | - |
| 2026-11-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-11-06 | Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended September 30 2026 | - |
| 2026-10-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-09-29 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-28 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-25 | Closure of Trading Window | - |
| 2026-09-24 | Intimation Under Regulation 30 And Para B Schedule III - Commencement Of Commercial Operations Of New IVF Centre/Hub At Gurgaon Haryana | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹97.40, within a 52-week range of ₹70.67 to ₹125.47. The P/E ratio is 32.10 and the P/B ratio is 4.56, with earnings per unit of ₹3.92. Market capitalisation stands at ₹739.22 Cr. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 19, 2026. This page covers 5 balance sheet periods, 8 income statement periods, 5 cash flow years and 6 shareholding periods. Information is provided for research and is not investment advice.